Clinical trials recruiting for Mismatch Repair Deficiency
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Alintegimod | 1 |
| Ipilimumab | 1 |
| Nivolumab | 1 |
| Toripalimab plus celecoxib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Colorado | 2 |
| Florida | 2 |
| Rhode Island | 2 |
| Texas | 2 |
| Alabama | 1 |
| Arizona | 1 |
| Arkansas | 1 |
| California | 1 |
| Connecticut | 1 |
| Delaware | 1 |
| Georgia | 1 |
| Idaho | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer
Related conditions
Trials recruiting for Mismatch Repair Deficiency often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Mismatch Repair Deficiency trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.